Thanks to The Atlantic, our previous “Universal cancer vaccine developed?” post found at The Telegraph has been demystified. Here is what Neal Emery writes for the Atlantic:
While a recent media report was more hype than science, it did focus on a promising pathway for cancer treatments.
More than 40 years after Nixon called for “a national commitment for the conquest of cancer”, is victory finally in sight?
An article published in the Telegraph on Sunday suggested that a weapon able to crush cancer had arrived. Headlined “‘Universal’ cancer vaccine developed”, the piece about Israeli Vaxil BioTherapeutics’ new drug ImMucin, has seen a deluge of interest.
Unlike November 2011 reports about the drug that were met with little fanfare, this piece has been covered by dozens of news outlets and shared 19,000 times on Facebook alone. According to the Telegraph, Vaxil’s wonderdrug, “which targets a molecule found in 90 percent of all cancers, could provide a universal injection that allows patients’ immune systems to fight off common cancers including breast and prostate cancer.”
Continue article HERE
3D visualizations of breast cells. Vivek Nandakumar/Arizona State University.